ABSTRACT: Photoinduced ligand dissociation of pyridine occurs much more readily in [Ru(tpy)(Me 2 bpy)(py)] 2+ than in [Ru(tpy)(bpy)(py)] 2+ (tpy = 2,2′:6′,2″-terpyridine; bpy = 2,2′-bipyridine, Me 2 bpy = 6,6′-dimethyl-2,2′-bipyridine; py = pyridine). The S 0 ground state and the 3 MLCT and 3 MC excited states of these complexes have been studied using BP86 density functional theory with the SDD basis set and effective core potential on Ru and the 6-31G(d) basis set for the rest of the atoms. In both complexes, excitation by visible light and intersystem crossing leads to a 3 MLCT state in which an electron from a Ru d orbital has been promoted to a π* orbital of terpyridine, followed by pyridine release after internal conversion to a dissociative . Analysis of the molecular orbitals along relaxed scans for stretching the Ru−N bonds reveals that ligand photodissociation is promoted by orbital mixing between the ligand π* orbital of tpy in the 3 MLCT state and the dσ* orbitals that characterize the dissociative 3 MC states. Good overlap and strong mixing occur when the Ru−N bond of the leaving ligand is perpendicular to the π* orbital of terpyridine, favoring the release of pyridine positioned in a cis fashion to the terpyridine ligand.
■ INTRODUCTION
There is a highly sustained interest in photoactivatable metal complexes for applications in the broad field of solar energy conversion, including the photocatalytic production of fuels from abundant sources and photovoltaic systems, as well as compounds that have increasing potential as tools in biomedical research. 1−5 Photoactivated compounds that release biologically active species from a nontoxic metal-based chaperone in the presence of light are being developed, so that the release can be accomplished with spatiotemporal control over biological activity. Their potential as selective and specific tools for biological research as well as agents for photoactivated chemotherapy (PACT) has been noted. 6−12 Photoinduced therapies are being developed for the treatments of various disease states, including cancer and microbial infections. 4−14 Active species currently being used include established inhibitors, neurotransmitters, drugs, and their derivatives. 15−17 Therapies that rely on photoactivation overcome the downfalls of those that are currently in use which lack the ability to achieve location-specific inhibition and have low bioavailability, leading to dose escalation, drug resistance, and intensified side effects. 18 A photoreleasable drug or inhibitor has the potential to minimize the risk and side effects by providing noninvasive methods for achieving high levels of control over the effects of drugs in diseased vs normal tissue.
Metal centers of interest include Pt(IV), 19 Re(I), 20 and Ir(III) 21 as well as complexes containing Ru(II), which have all been investigated extensively. Photoactivatable Ru(II)-centered chaperones are typically composed of tridentate or bidentate chelators, such as 2,2′:6′,2″-terpyridine (tpy), 2,2′-bipyridine (bpy), and 1,10-phenanthroline (phen) and their derivatives as ancillary ligands and one or more monodentate ligands as the active species for release. The low ligand exchange in Ru(II) complexes observed in the dark, together with their high photoreactivity, makes these complexes highly attractive as potential PACT agents. In photochemotherapy, absorption of a photon by the complex opens coordination sites on the ruthenium for binding to biomolecules, including DNA and proteins. Alternatively, the photodissociation can be used to release reactive molecules and species while the leftover ruthenium fragment is not toxic, which is a highly desirable property for chemical tools. The efficiency of a PACT agent is typically rated on the basis of its relative efficacy upon irradiation in comparison to dark conditions. Chaperone complexes that can release two or three monodentate active nitrile species have also been previously developed. 4, 22, 23 In these compounds, only one of the biologically active ligands usually dissociates efficiently upon irradiation.
Whereas much of the initial work in the field focused on the photorelease of nitrile-bound inhibitors and drugs, the Turro group recently designed a photoactive Ru(II) complex able to deliver pyridine and pyridine-bound inhibitors efficiently with low-energy visible light, a requirement for tissue penetration. 24 The release of pyridine and other N-heterocycles is important due to the very large number of active agents available that contain these functional groups, opening the field of PACT to include compounds that can achieve a method of cell death independent of oxygen concentration, 12 unlike the case for photodynamic therapy, which requires oxygen. When the octahedral orientation is distorted using 6,6′-dimethyl-2,2′-bipyridine (Me 2 bpy), these complexes become more photoreactive. Figure S1 and S2 of the Supporting Information. 
■ COMPUTATIONAL METHODS
Electronic structure calculations were performed using Gaussian 09 39 and the BP86 density functional. 40, 41 For a set of Ru(II) polypyridyl complexes, Gonzalez and co-workers 42 found that BP86 showed the best state ordering and state mixing in comparison to MS-CASPT2 calculations. In preparation for our earlier study, 38 we examined a number of different functionals and found that the 3 MC state of a RuTQA complex was 3−27 kcal/mol lower in energy than the 3 MLCT state. The BP86 functional gave the smallest energy difference between the 3 MLCT and 3 MC states, whereas the hybrid functionals gave the largest energy differences. The SDD basis set and effective core potential 43−45 were used for the central Ru atom. The 6-31G(d) basis set 46, 47 was used for the other atoms. Solvation effects in methanol were incorporated by using the implicit SMD solvation model 48 and were included during structure optimization. The optimized structures were confirmed to be minima by harmonic vibrational frequency calculations. The 1 S 0 , 3 
MLCT, and
3 MC electronic configurations were tested for SCF stability and were characterized by examining the molecular orbital populations and the spin densities. GaussView 49 was used to generate isodensity plots of the spin densities (isovalue 0.004 au), the canonical orbitals, and biorthogonal/corresponding orbitals 50 (isovalue 0.04 au). To explore the potential energy surfaces for dissociation, relaxed potential energy surface scans were performed by stretching selected Ru−N bonds while the remaining coordinates were optimized. Transition states were obtained by optimizing the highest energy structures of the relaxed scans and were confirmed to have only one imaginary vibrational frequency.
■ RESULTS AND DISCUSSION
The photoinduced ligand dissociation in the [Ru(tpy)(bpy)-(py)] 2+ and [Ru(tpy)(Me 2 bpy)(py)] 2+ complexes (Scheme 1) has been studied experimentally and reported previously. 24, 34 Upon irradiation with visible light, the pyridine ligand MLCT state puts an electron in the tpy π* orbital, and the nodal patterns of this orbital explain the bond length changes in the tpy ligand seen on excitation (see Table S1 in the Supporting Information).
Inorganic Chemistry
Stretching the Ru−N 6 bond in the 3 MLCT optimized structure results in conversion to the 3 MC 1 state. Geometry optimization of the 3 MC 1 structure leads to a weakly bound sixcoordinate structure which dissociates to a five-coordinate complex and a free pyridine that is about 2 kcal/mol higher in energy. Because SOMO 2 is a dσ* orbital aligned with both the Ru−N 6 and Ru−N 5 bonds, the latter is also somewhat elongated (Table 1 ). Figure 3 , respectively. The difference can be attributed to the release of strain from interaction between tpy and the methyl group of Me 2 bpy in the latter complex. In the 3 MC 2 structure, the Ru−N 5 bond elongates and the N 5 pyridyl group of bpy rotates away from Ru. MC involves electron transfer from the tpy ligand to Ru, some changes are also observed in the bond length of the tpy ligand (see Table S1 in the Supporting Information). (Figure 7) . The higher barriers for breaking the Ru−N 4 bond are consistent with experiment, which did not find photodissociation of the bpy ligand.
MO Analysis along the Relaxed Scans. In our previous study 38 we analyzed the SOMOs along the relaxed potential energy scans and found that photodissociation of the nitrilebound Ru polypyridyl complexes is facilitated by orbital mixing between the ligand π* orbital of the 3 MLCT state and the Ru dσ* orbitals of a dissociative 3 MC state. Figure 8 shows the corresponding plots for the SOMOs of [Ru(tpy)(Me 2 bpy)(py)] 2+ as MLCT state is a ligand-based π* orbital on tpy. When the Ru−N 6 bond is stretched longer than 2.52 Å, the ligandbased SOMO 2 mixes with the dσ 1 * orbital of Ru, which corresponds to SOMO 2 of 3 MC 1 (Figure 8a ). This orbital mixing promotes dissociation because the dσ 1 * orbital involves an antibonding interaction with the pyridine ligand. Stretching the Ru−N 5 bond (trans to Ru−N 6 ) also leads to similar orbital mixing of the tpy π* orbital and the Ru dσ 1 * orbital (Figure 8b) . However, the Ru−N 5 bond does not dissociate because the bpy ligand is still tethered by the Ru−N 4 bond. Further elongation of the Ru−N 5 bond results in an increase in energy because of the twisting of the bpy ligand. In contrast to the orbital mixing seen when the Ru−N 5 and Ru−N 6 bonds are stretched, when the Ru−N 4 bond is stretched, the π* orbital of tpy remains orthogonal to the Ru dσ 2 * orbital that corresponds to SOMO 2 of 3 MC 3 , and no mixing occurs (Figure 8c ). In addition, the rigidity of the bpy ligand restricts the motion of the Ru−N 4 bond. As a result, the barrier for the transition to the . By analyzing the molecular orbitals along relaxed scans for stretching the Ru−N bonds, we find that ligand photodissociation is promoted by orbital mixing between the ligand π* orbital of the 3 MLCT state and the dσ* orbitals that characterize the dissociative 3 MC states. Mixing can occur when the Ru−N 6 bond perpendicular to a π-acceptor ligand is stretched and the π* orbital of tpy and the dσ* orbital of Ru have good overlap. Orbital mixing results in a smooth and continuous transition from The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.inorgchem.7b02398.
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